Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Rangering i aksjer #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Aksjekurs
$0.83030862
Sist synkronisert: 2024-06-27
Markedsverdi
$726.64K
Endring (1 dag)
-1.35%
Endring (1 år)
0.00%
Land
DE
Handel Epigenomics AG (ECX)

Kategori

Pris ECX pris med markedsverdi på B
Epigenomics AG Epigenomics AG
ECX
$0.83030862
Markedsverdi av Epigenomics AG(ECX)
Markedsverdi: $726.64K
Per August 2026 har Epigenomics AG en markedsverdi på $726.64K. Dette gjør Epigenomics AG til det 38936th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Epigenomics AG fra 2014 til 2026
ECX sammenlignet med topp 5 mest populære stocks
Pris på ECX Eiendel B Markedsverdi for B Resultater
Epigenomics AG Epigenomics AG
$6,249,829 $726.64K
$5.470T +752,711,453.14%
Epigenomics AG Epigenomics AG
$5,104,349 $726.64K
$4.467T +614,753,146.04%
Epigenomics AG Epigenomics AG
$4,769,494 $726.64K
$4.174T +574,424,088.62%
Epigenomics AG Epigenomics AG
$4,227,935 $726.64K
$3.700T +509,200,320.84%
Epigenomics AG Epigenomics AG
$3,261,547 $726.64K
$2.854T +392,811,288.04%